Cardiometabolic
Multi-organ services delivered through quantitative MRI and DXA to support obesity, metabolic, and neuromuscular disease-focused clinical trials.
Body composition
Our body composition analysis measures changes in fat deposition and lean muscle at various anatomical locations in both 2D and 3D, allowing the tracking of changes in participant phenotypes, moving beyond ‘weight loss’ alone.
Metrics included are:
- Skeletal muscle
- Visceral adipose tissue (VAT)
- Subcutaneous adipose tissue (SAT)
- Suspected brown adipose tissue (sBAT)
- Muscle Fat infiltration
Multi-organ imaging and ectopic fat deposition
Emerging obesity and MetD treatments – including GLP-1 RAs – have demonstrated robust improvements in multi-organ health. Capture these systemic improvements through our multi-organ imaging portfolio.
DXA
Understand body composition and bone health through a standardized and centralized reporting service, ensuring quality assurance and reliable data insights encapsulated within a configurable and customizable reporting structure.
- Lean mass
- Fat mass
- Total mass
- Percentage body fat
- Bone mineral density T-scores
Renal imaging
Our renal imaging suite delivers an extensive assessment of structural and functional metrics that can be used to screen for eligible patients and assess therapeutic efficacy. We bring a rich knowledge base with dedicated experts and a proven track record of innovation in the space of renal imaging, with 30 years of industry experience and 100+ publications in peer-reviewed journals.
Cardiac imaging
Using our cardiac imaging services, comprehensive assessments of cardiac structure and function can be carried out in a sub 30 minute non-contrast scan – maximising patient comfort and scanner capacity.
.png)
Establishing imaging network
Our established imaging network has locations across the globe, paired with our in-house developed central platform we can scale our services to meet the most comprehensive and complex clinical trial requirements.
